SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054452
Filing Date
2024-05-07
Accepted
2024-05-07 16:03:34
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20240331.htm   iXBRL 10-Q 1563920
2 EX-31.1 rphm-ex31_1.htm EX-31.1 16379
3 EX-31.2 rphm-ex31_2.htm EX-31.2 15913
4 EX-32.1 rphm-ex32_1.htm EX-32.1 14614
5 GRAPHIC img28448619_0.jpg GRAPHIC 11204
  Complete submission text file 0000950170-24-054452.txt   5915770

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rphm-20240331.xsd EX-101.SCH 992535
65 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20240331_htm.xml XML 825808
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 24921703
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)